MDLinx E-mail Article

To email this article, enter your own "From Email" address, the recipient's "To Email" address, and click the "Send Email" button. You may send to up to 5 emails at a time.


* From Email: 
* To Email: 
To Email: 
To Email: 
To Email: 
To Email: 
Email Subject Line: 
Comments:

Early Administration of Low-Dose Aspirin for the Prevention of Preterm and Term Preeclampsia: A Systematic Review and Meta-Analysis

Roberge S et al. – Low–dose aspirin administrated at or before 16 weeks of gestation reduces the risk of preterm but not term preeclampsia.

Methods
  • A systematic review and meta–analysis of randomized controlled trials were performed.
  • Women who were randomized to low–dose aspirin or placebo/no treatment at or before 16 weeks of gestation were included.
  • The outcomes of interest were preterm preeclampsia (delivery <37 weeks) and term preeclampsia.
  • Pooled relative risks (RR) with their 95% confidence intervals (CI) were computed.

Results
  • The search identified 7,941 citations but only five trials on a combined total of 556 women fulfilled the inclusion criteria.
  • When compared to controls, aspirin initiated ≤16 weeks of gestation was associated with a major reduction of the risk of preterm preeclampsia (RR 0.11, 95% CI 0.04–0.33) but had no significant effect on term preeclampsia (RR 0.98, 95% CI 0.42–2.33).
[more...]

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close